Veronique Keppenne

Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Long-term persistence of intradetrusor botulinum toxin in patients with multiple sclerosis.

Long-term persistence of intradetrusor botulinum toxin in patients with multiple sclerosis.

Journal: The French journal of urology

Published: December 23, 2025

Clean intermittent catheterization in multiple sclerosis patients: An adherence and long-term follow-up study.

Clean intermittent catheterization in multiple sclerosis patients: An adherence and long-term follow-up study.

Journal: The French journal of urology

Published: April 28, 2024

Intermittent catheterisation: individuals' rights, accessibility, and environmental concerns.

Intermittent catheterisation: individuals' rights, accessibility, and environmental concerns.

Journal: Spinal cord series and cases

Published: November 23, 2023

The overactive bladder syndrome

The overactive bladder syndrome

Journal: Revue medicale de Liege

Published: June 23, 2023

Intermittent catheterization: A patient-centric approach is key to optimal management of neurogenic lower urinary tract dysfunction.

Intermittent catheterization: A patient-centric approach is key to optimal management of neurogenic lower urinary tract dysfunction.

Journal: Frontiers in urology

Published: February 03, 2023

Intermittent catheterization: Clinical practice guidelines from Association Française d'Urologie (AFU), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP).

Intermittent catheterization: Clinical practice guidelines from Association Française d'Urologie (AFU), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP).

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: October 14, 2019

Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS.

Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS.

Journal: Neurology

Published: July 27, 2017

Not Available

Not Available

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: October 14, 2015

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.

Journal: Advances in therapy

Published: July 15, 2013

Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.

Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.

Journal: The Journal of urology

Published: October 28, 2011

Neuromodulation in the management of neurogenic lower urinary tract dysfunction

Neuromodulation in the management of neurogenic lower urinary tract dysfunction

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: July 12, 2007

Showing 1-11 of 11

Last Updated: 09/26/2026